Overlap between adverse events (AEs) and serious adverse events (SAEs): a case study of a phase III cancer clinical trial
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1745-6215
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Overlap between adverse events (AEs) and serious adverse events (SAEs): a case study of a phase III cancer clinical trial ; volume:21 ; number:1 ; day:17 ; month:9 ; year:2020 ; pages:1-8 ; date:12.2020
Trials ; 21, Heft 1 (17.9.2020), 1-8, 12.2020
- Urheber
-
James, Elizabeth C.
Dunn, David
Cook, Adrian D.
Clamp, Andrew R.
Sydes, Matthew R.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13063-020-04718-z
- URN
-
urn:nbn:de:101:1-2020110620494871344559
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:30 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- James, Elizabeth C.
- Dunn, David
- Cook, Adrian D.
- Clamp, Andrew R.
- Sydes, Matthew R.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Serious adverse events and fatal adverse events associated with nivolumab treatment in cancer patients : Nivolumab-related serious/fatal adverse events
Correction to: Serious adverse events and fatal adverse events associated with nivolumab treatment in cancer patients
Postmarketing Surveillance of Full Spectrum Hemp Extract CBD Products: Reported Adverse Events and Serious Adverse Events
Adverse event signal mining and serious adverse event influencing factor analysis of fulvestrant based on FAERS database
Serious Cardiovascular Adverse Events Reported with Intravenous Sedatives: A Retrospective Analysis of the MedWatch Adverse Event Reporting System
Hyperglycemic adverse events following antipsychotic drug administration in spontaneous adverse event reports
Modeling an IT Support for Handling Serious Adverse Events in Clinical Trials
Clinical Trials Facing “Serious Adverse Events” during the Ongoing COVID-19 Pandemic
Categorisation of Pharmaceutical Adverse Events Using the Japanese Adverse Drug Event Report Database: Characteristic Adverse Drug Events of the Elderly Treated with Polypharmacy
Rare Immune-Related Adverse Events (irAEs): Approach to Diagnosis and Management
Adverse event profiles of microscopic colitis in the Japanese Adverse Drug Event Report (JADER) database
Visualization of Kinase Inhibition-Related Adverse Events Using the Japanese Adverse Drug Event Report Database
Serious adverse events and fatal adverse events associated with nivolumab treatment in cancer patients : Nivolumab-related serious/fatal adverse events
Correction to: Serious adverse events and fatal adverse events associated with nivolumab treatment in cancer patients
Postmarketing Surveillance of Full Spectrum Hemp Extract CBD Products: Reported Adverse Events and Serious Adverse Events
Adverse event signal mining and serious adverse event influencing factor analysis of fulvestrant based on FAERS database
Serious Cardiovascular Adverse Events Reported with Intravenous Sedatives: A Retrospective Analysis of the MedWatch Adverse Event Reporting System
Hyperglycemic adverse events following antipsychotic drug administration in spontaneous adverse event reports
Modeling an IT Support for Handling Serious Adverse Events in Clinical Trials
Clinical Trials Facing “Serious Adverse Events” during the Ongoing COVID-19 Pandemic
Categorisation of Pharmaceutical Adverse Events Using the Japanese Adverse Drug Event Report Database: Characteristic Adverse Drug Events of the Elderly Treated with Polypharmacy
Rare Immune-Related Adverse Events (irAEs): Approach to Diagnosis and Management
Adverse event profiles of microscopic colitis in the Japanese Adverse Drug Event Report (JADER) database
Visualization of Kinase Inhibition-Related Adverse Events Using the Japanese Adverse Drug Event Report Database
Serious adverse events and fatal adverse events associated with nivolumab treatment in cancer patients : Nivolumab-related serious/fatal adverse events
Correction to: Serious adverse events and fatal adverse events associated with nivolumab treatment in cancer patients
Postmarketing Surveillance of Full Spectrum Hemp Extract CBD Products: Reported Adverse Events and Serious Adverse Events
Adverse event signal mining and serious adverse event influencing factor analysis of fulvestrant based on FAERS database
Serious Cardiovascular Adverse Events Reported with Intravenous Sedatives: A Retrospective Analysis of the MedWatch Adverse Event Reporting System
Hyperglycemic adverse events following antipsychotic drug administration in spontaneous adverse event reports
Modeling an IT Support for Handling Serious Adverse Events in Clinical Trials
Clinical Trials Facing “Serious Adverse Events” during the Ongoing COVID-19 Pandemic
Categorisation of Pharmaceutical Adverse Events Using the Japanese Adverse Drug Event Report Database: Characteristic Adverse Drug Events of the Elderly Treated with Polypharmacy
Rare Immune-Related Adverse Events (irAEs): Approach to Diagnosis and Management
Adverse event profiles of microscopic colitis in the Japanese Adverse Drug Event Report (JADER) database